[Interview] A Company on the Cutting Edge of COVID-19 Vaccine Development

Recently, COVAXX announced it would soon enter human trials as the company is focused on rapidly developing a Multitope Peptide-based Vaccine (MPV) against SARS-CoV-2. While the biotech industry is now on a race to develop vaccines to curb COVID-19 pandemics, with several dozen players competing for the future market, COVAXX is a special case that […]

A Conversation With Professor Josef Penninger on the Journey to a COVID-19 Therapeutic

Angiotensin-converting enzyme 2 (ACE2) – the receptor used by the SARS-CoV-2 virus as a gateway to enter and infect host cells – has garnered significant attention for the wrong reasons over recent months. But could it also point towards an exit route out of this pandemic? In an interview with Technology Networks, the renowned immunologist […]

The Scott Becker Business Podcast: David Schull, President of Russo Partners

In this episode features to David Schull, President of Russo Partners. Here, he discusses his strategies for gaining traction with clients, how he balances building relationships without being pushy, and more.